Skip to main content
SpringerLink
Log in

European Lead Factory hits its stride

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

An Erratum to this article was published on 01 June 2016

An Erratum to this article was published on 06 April 2016

This article has been updated

A large European drug discovery consortium is making inroads into novel chemical and biological space.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

  • 06 April 2016

    In the version of this article originally published, the name Ton Rijnders was misspelt, and the number of options notices that have been triggered was incorrectly reported. These errors have been corrected in the online and PDF versions of the article.

  • 01 June 2016

    In the version of the article originally published, Merck & Co. was incorrectly listed as one of the pharmaceutical partners of the European Lead Factory, instead of Merck KGaA. This error has been corrected in the online versions of the article.

Authors
  1. Katie Kingwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kingwell, K. European Lead Factory hits its stride. Nat Rev Drug Discov 15, 221–222 (2016). https://doi.org/10.1038/nrd.2016.64

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.64

  • Springer Nature Limited

This article is cited by

Search

Navigation